MSB 3.21% $1.13 mesoblast limited

Here is the main point. Merck's trial was stopped for...

  1. 17,007 Posts.
    lightbulb Created with Sketch. 2410
    Here is the main point. Merck's trial was stopped for overwheming efficacy.
    MSB's trial was stopped for futility.
    Merck: 1, MSB: 0

    If MSB wants to get approval, they need to do a new trial and investors need to hope it does better.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.